A pilot study of effects of exenatide on body weight in non-diabetic, obese patients

Trial Profile

A pilot study of effects of exenatide on body weight in non-diabetic, obese patients

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2014

At a glance

  • Drugs Exenatide (Primary)
  • Indications Obesity
  • Focus Therapeutic Use
  • Sponsors Amylin Pharmaceuticals
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Mar 2010 Results in patients with or without pre-diabetes were reported in Diabetes Care.
    • 11 Jun 2009 Results have been published as an abstract in the proceedings of the 91st Annual Meeting of the Endocrine Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top